Dr. Rani E George MD PHD
Hematologist (Pediatric) | Pediatric Hematology-Oncology
44 Binney St Dana 322 Dept Of Ped Boston MA, 02115About
Dr. Rani George is a pediatric hematologist practicing in Boston, MA. Dr. George specializes in treating children that have a blood disease or cancer. Such blood diseases include disorders of red blood cells, white blood cells and/or platelets. The types of cancers that Dr. George treats include leukemias, lymphomas and certain tumors. Dr. George can also treat bleeding disorders in children. Pediatric hematologists can be found in childrens hospitals, community hospitals, university medical centers and more.
Education and Training
Univ of Liberia, Am Dogliotti Coll of Med, Monrovia, Liberia 1985
A. M. Dogliotti College of Medicine 1986
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.
- Zebrafish foxd3 is selectively required for neural crest specification, migration and survival.
- Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study.
- Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell.
- Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis.
- Pharmacotherapy of neuroblastoma.
- Discovery of 3,5-Diamino-1,2,4-triazole Ureas as Potent Anaplastic Lymphoma Kinase Inhibitors.
- Emerging importance of ALK in neuroblastoma.
- Activated ALK collaborates with MYCN in neuroblastoma pathogenesis.
- The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.
- Distinct neuroblastoma-associated alterations of PHOX2B impair sympathetic neuronal differentiation in zebrafish models.
- Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma.
- CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer.
- Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor.
- Seek and Ye Shall Find: Subclonal Anaplastic Lymphoma Kinase Mutations.
Dr. Rani E George MD PHD's Practice location
Dr. Rani E George MD PHD's reviews
Write ReviewRecommended Articles
- Breast Cancer Survivor Organizes Non-Profit With a Meaningful Purpose
One month before her 31st birthday, Janet Palmer, a law enforcement officer, found a lump in her right breast. After nine months of consultations with two different doctors and one negative mammogram, she was diagnosed with breast cancer. At this time, Palmer decided to undergo a mastectomy,...
- What are the Dangers of Brain-Eating Amoeba?
Brain-eating amoeba is a terrifying organism that seems to cause sudden, tragic deaths of some people in our country. The amoeba, Naegleria fowleri, was first identified in Australia. The species has five sub-types, all of which causes diseases. The species remains in an inactive cyst form when...
- Purpura
PurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
- How Is Leukemia Diagnosed?
Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
Nearby Providers
- Dr. Giannoula Lakka Klement MD800 Washington St Boston MA 02111
- Dr. Christina K Ullrich M.D.44 Binney St Boston MA 02115
- Dr. Kapil Saxena MD300 Longwood Ave # Fegan707 Boston MA 02115
- Dr. Eva Catharina Guinan MD44 Binney St Boston MA 02115
- Dr. Susan E Prockop MD300 LONGWOOD AVE BOSTON MA 02115
- Dr. Lillian E. c. Mcmahon M.D.732 Harrison Ave Boston MA 02118